Promising results for stem cell treatment after heart attack

A comprehensive new analysis suggests that stem cell therapy can be of some benefit to heart attack patients.

The Cochrane review, carried out by Dr Enca Martin-Rendon of the John Radcliffe Hospital in Oxford, UK, and colleagues, looked at 33 clinical trials.

The authors explain that heart cells which have died due to oxygen shortage in a heart attack can leave a large part of the heart unable to contract. This can then cause further heart problems.

Earlier this week researchers reported success using cells taken from the heart to repair damaged organs. Today’s analysis looks at the effectiveness of using stem cells taken from bone marrow after a heart attack.

As it is not yet widely carried out, the researchers measured its success in 1,765 heart attack patients who had undergone angioplasty, in which a balloon opens the blocked artery to reintroduce blood supply.

Overall, stem cell therapy using bone marrow-derived stem cells was shown to produce a "moderate long-term improvement in heart function which is sustained for up to five years". But the figures could not show whether it boosts survival rates.

"This new treatment may lead to moderate improvement in heart function over standard treatments," said Dr Martin-Rendon.

"Stem cell therapy may also reduce the number of patients who later die or suffer from heart failure, but currently there is a lack of statistically significant evidence based on the small number of patients treated so far."

The authors say it is still too early for standard guidelines because cell dosage, timing of cell transplantation and methods to measure heart function still need to be established.

"The studies were hard to compare because they used so many different methods," said Dr Martin-Rendon. "Larger trials with standardised treatment procedures would help us to know whether this treatment is really effective."

Professor Peter Weissberg, medical director of the British Heart Foundation, said: “This review reflects the consensus of opinion about these trials – cell therapy has a modestly beneficial effect.

"Despite that, no one knows why, or even if, cell therapies will translate into better survival or sustained improvement in damaged hearts. It’s much too early to judge the likely long-term benefits."

Stem cell treatment for acute myocardial infarction. Clifford, D. M. et al. Cochrane Database of Systematic Reviews February 15 2012 Issue 2 doi: 10.1002/14651858.CD006536.pub3

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index